GW Pharmaceuticals (Ticker GWPH) is a British biopharmaceutical company known for its multiple sclerosis treatment product nabiximols which was the first natural cannabis plant derivative to gain market approval in any country. Another cannabis-based product, Epidiolex, for treatment of epilepsy was approved for treatment of epilepsy in 2018.
Absolutely got to agree with this, MMJ medical Marijuana is taking off! Now is a good time to invest …
1 Like
I’d love to invest most my money into this:)
1 Like
UK based CBD pharma. Please add!!
1 Like
Any news on this?
Bump too!
1 Like
Bump… 
I just committed to this platform, because of the positive talks of cannabis stocks becoming available. I shall upvote on all the requests. GW pharma is a no brainier for UK company, in CBD and medical use.
Would love to see on the platform…
1 Like
And/or the Rize Medical Cannabis ETF?
2 Likes
What happened to this? It’s featured in the latest Freetrade email but I can’t find it on the app.
Are you looking on isa or basic? It should be in the basic
Ah I was in my ISA, thanks.
Wasn’t aware there were different stocks on basic vs ISA. Why is that?
In short, governmental regulations
Edit:
3 Likes
HMRC regulations, to be exact.
HMRC have list of criteria what stocks can or cannot be in an ISA, and FT follows that same as any other broker.
2 Likes
Why has this cratered 20%? I can’t see any bad news in the results apart from one analyst claiming bad physician feedback.
Just got sold for $7.2bn
CBDX/CBDP LN has a 14% allocation to GWP. shot up 10% today
1 Like